Compounds > safingol

safingol and Colonic Neoplasms

safingol has been researched along with Colonic Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Błachnio-Zabielska, AU; Markowska, AJ; Markowski, AR; Pogodzińska, K; Zabielski, P1
Hu, L; Mu, Y; Wu, B; Wu, Y; Xia, L; Yan, J; Zhou, H1
Chiu, GN; Lin, H; Ling, LU; Tan, KB1
Ahn, EH; Schroeder, JJ2
Entschladen, F; Lang, K; Masur, K; Niggemann, B; Zanker, KS1

Other Studies

6 other study(ies) available for safingol and Colonic Neoplasms

ArticleYear
Diverse Sphingolipid Profiles in Rectal and Colon Cancer.
    International journal of molecular sciences, 2023, Jun-29, Volume: 24, Issue:13

    Topics: Ceramides; Colonic Neoplasms; Colorectal Neoplasms; Humans; Lysophospholipids; Rectal Neoplasms; Sphingolipids; Sphingosine

2023
TF/FVIIa/PAR2 promotes cell proliferation and migration via PKCα and ERK-dependent c-Jun/AP-1 pathway in colon cancer cell line SW620.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2013, Volume: 34, Issue:5

    Topics: Antineoplastic Agents; Butadienes; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colonic Neoplasms; Curcumin; Extracellular Signal-Regulated MAP Kinases; Factor VIIa; Humans; MAP Kinase Signaling System; Nitriles; Protein Kinase C-alpha; Proto-Oncogene Proteins c-jun; Receptor, PAR-2; Sphingosine; Thromboplastin; Transcription Factor AP-1

2013
The role of protein kinase C in the synergistic interaction of safingol and irinotecan in colon cancer cells.
    International journal of oncology, 2009, Volume: 35, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Camptothecin; Cell Adhesion; Cell Survival; Colonic Neoplasms; Drug Synergism; HT29 Cells; Humans; Irinotecan; Protein Kinase C; Sphingosine

2009
Induction of apoptosis by sphingosine, sphinganine, and C(2)-ceramide in human colon cancer cells, but not by C(2)-dihydroceramide.
    Anticancer research, 2010, Volume: 30, Issue:7

    Topics: Apoptosis; Cell Cycle; Cell Division; Ceramides; Colonic Neoplasms; G2 Phase; HCT116 Cells; HT29 Cells; Humans; Sphingosine

2010
High PKC alpha and low E-cadherin expression contribute to high migratory activity of colon carcinoma cells.
    Molecular biology of the cell, 2001, Volume: 12, Issue:7

    Topics: Acetophenones; Benzopyrans; Biological Transport; Cadherins; Carbazoles; Cell Membrane; Cell Movement; Colonic Neoplasms; Enzyme Activation; Enzyme Inhibitors; Humans; Indoles; Isoenzymes; Oligonucleotides, Antisense; Protein Kinase C; Protein Kinase C-alpha; Protein Kinase C-delta; Sphingosine; Tumor Cells, Cultured

2001
Sphingoid bases and ceramide induce apoptosis in HT-29 and HCT-116 human colon cancer cells.
    Experimental biology and medicine (Maywood, N.J.), 2002, Volume: 227, Issue:5

    Topics: Apoptosis; Cell Cycle; Cell Division; Ceramides; Colonic Neoplasms; DNA Fragmentation; Dose-Response Relationship, Drug; Flow Cytometry; HT29 Cells; Humans; Microscopy, Fluorescence; Sphingosine; Structure-Activity Relationship; Tumor Cells, Cultured

2002